Comparison of different concentrations of calcium gluconate added in replacement fluid to maintain ionised calcium levels during therapeutic plasma exchange procedures
- 20 November 2024
- journal article
- research article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 64 (1) , 104039
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special IssueJournal of Clinical Apheresis, 2019
- Prophylactic infusion of calcium gluconate to prevent a symptomatic fall in plasma ionized calcium during therapeutic plasma exchange: A comparison of two methodsJournal of Clinical Apheresis, 2018
- Prophylactic low dose continuous calcium infusion during peripheral blood stem cell (PBSC) collections to reduce citrate related toxicityTransfusion and Apheresis Science, 2016
- Continuous infusion of calcium gluconate in 5% albumin is safe and prevents most hypocalcemic reactions during therapeutic plasma exchangeJournal of Clinical Apheresis, 2007
- Reduction of adverse citrate reactions during autologous large‐volume PBPC apheresis by continuous infusion of calcium‐gluconateTransfusion, 2003
- Comprehensive analysis of citrate effects during plateletpheresis in normal donorsTransfusion, 2001
- Hypocalcemic toxicity and atypical reactions in therapeutic plasma exchangeJournal of Clinical Apheresis, 2001
- Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1991
- Panel IV: Dosage regimens for citrate anticoagulantsJournal of Clinical Apheresis, 1983
- Treatment of Waldenström's Macroglobulinemia by PlasmapheresisNew England Journal of Medicine, 1960